These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
63 related items for PubMed ID: 15514114
1. The consequences of insulin-like growth factors/receptors dysfunction in lung cancer. Pavelic J, Krizanac S, Kapitanovic S, Pavelic L, Samarzija M, Pavicic F, Spaventi S, Jakopovic M, Herceg-Ivanovi Z, Pavelic K. Am J Respir Cell Mol Biol; 2005 Jan; 32(1):65-71. PubMed ID: 15514114 [Abstract] [Full Text] [Related]
2. Insulin-like growth factor 2 and its receptors (IGF 1R and IGF 2R/mannose 6-phosphate) in endometrial adenocarcinoma. Pavelić J, Radaković B, Pavelić K. Gynecol Oncol; 2007 Jun; 105(3):727-35. PubMed ID: 17399767 [Abstract] [Full Text] [Related]
3. Gastric cancer: the role of insulin-like growth factor 2 (IGF 2) and its receptors (IGF 1R and M6-P/IGF 2R). Pavelić K, Kolak T, Kapitanović S, Radosević S, Spaventi S, Kruslin B, Pavelić J. J Pathol; 2003 Nov; 201(3):430-8. PubMed ID: 14595755 [Abstract] [Full Text] [Related]
4. Expressions of insulin-like growth factor receptor-1 and insulin-like growth factor binding protein 3 in advanced non-small-cell lung cancer. Kim YH, Sumiyoshi S, Hashimoto S, Masago K, Togashi Y, Sakamori Y, Okuda C, Mio T, Mishima M. Clin Lung Cancer; 2012 Sep; 13(5):385-90. PubMed ID: 22285568 [Abstract] [Full Text] [Related]
5. IGF-1 and its receptor in esophageal cancer: association with adenocarcinoma and visceral obesity. Doyle SL, Donohoe CL, Finn SP, Howard JM, Lithander FE, Reynolds JV, Pidgeon GP, Lysaght J. Am J Gastroenterol; 2012 Feb; 107(2):196-204. PubMed ID: 22146489 [Abstract] [Full Text] [Related]
6. Expression of PTEN and FHIT is involved in regulating the balance between apoptosis and proliferation in lung carcinomas. Zheng H, Tsuneyama K, Takahashi H, Miwa S, Nomoto K, Saito H, Masuda S, Takano Y. Anticancer Res; 2007 Feb; 27(1B):575-81. PubMed ID: 17348444 [Abstract] [Full Text] [Related]
7. M6P/IGF2R is mutated in squamous cell carcinoma of the lung. Kong FM, Anscher MS, Washington MK, Killian JK, Jirtle RL. Oncogene; 2000 Mar 16; 19(12):1572-8. PubMed ID: 10734317 [Abstract] [Full Text] [Related]
8. Alteration of the insulin-like growth factor axis during in vitro differentiation of the human osteosarcoma cell line HOS 58. Viereck V, Siggelkow H, Pannem R, Braulke T, Scharf JG, Kübler B. J Cell Biochem; 2007 Sep 01; 102(1):28-40. PubMed ID: 17372931 [Abstract] [Full Text] [Related]
9. The rationale and development of therapeutic insulin-like growth factor axis inhibition for lung and other cancers. Camidge DR, Dziadziuszko R, Hirsch FR. Clin Lung Cancer; 2009 Jul 01; 10(4):262-72. PubMed ID: 19632946 [Abstract] [Full Text] [Related]
10. Recombinant adenoviruses expressing dominant negative insulin-like growth factor-I receptor demonstrate antitumor effects on lung cancer. Lee CT, Park KH, Adachi Y, Seol JY, Yoo CG, Kim YW, Han SK, Shim YS, Coffee K, Dikov MM, Carbone DP. Cancer Gene Ther; 2003 Jan 01; 10(1):57-63. PubMed ID: 12489029 [Abstract] [Full Text] [Related]
11. The 3' UTR IGF2R-A2/B2 variant is associated with increased tumor growth and advanced stages in non-small cell lung cancer. Kotsinas A, Evangelou K, Sideridou M, Kotzamanis G, Constantinides C, Zavras AI, Douglass CW, Papavassiliou AG, Gorgoulis VG. Cancer Lett; 2008 Feb 08; 259(2):177-85. PubMed ID: 18037232 [Abstract] [Full Text] [Related]
12. [Molecular pathology of lung cancer and insulin-like growth factors]. Kogan EA, Jaques G. Arkh Patol; 1999 Feb 08; 61(5):55-61. PubMed ID: 10598264 [Abstract] [Full Text] [Related]
13. Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer. Metzger R, Vallbohmer D, Müller-Tidow C, Higashi H, Bollschweiler E, Warnecke-Eberz U, Brabender J, Baldus SE, Xi H, Berdel WE, Serve H, Hoelscher AH, Schneider PM. Anticancer Res; 2009 Apr 08; 29(4):1157-62. PubMed ID: 19414359 [Abstract] [Full Text] [Related]
14. High-level expression of CD109 is frequently detected in lung squamous cell carcinomas. Sato T, Murakumo Y, Hagiwara S, Jijiwa M, Suzuki C, Yatabe Y, Takahashi M. Pathol Int; 2007 Nov 08; 57(11):719-24. PubMed ID: 17922683 [Abstract] [Full Text] [Related]
15. Loss of FHIT function in lung cancer and preinvasive bronchial lesions. Sozzi G, Pastorino U, Moiraghi L, Tagliabue E, Pezzella F, Ghirelli C, Tornielli S, Sard L, Huebner K, Pierotti MA, Croce CM, Pilotti S. Cancer Res; 1998 Nov 15; 58(22):5032-7. PubMed ID: 9823304 [Abstract] [Full Text] [Related]
16. Interleukin-8 in non-small cell lung carcinoma: relation with angiogenic pattern and p53 alterations. Boldrini L, Gisfredi S, Ursino S, Lucchi M, Mussi A, Basolo F, Pingitore R, Fontanini G. Lung Cancer; 2005 Dec 15; 50(3):309-17. PubMed ID: 16125276 [Abstract] [Full Text] [Related]
17. Significance of EGFR protein expression and gene amplification in non-small cell lung carcinoma. Dacic S, Flanagan M, Cieply K, Ramalingam S, Luketich J, Belani C, Yousem SA. Am J Clin Pathol; 2006 Jun 15; 125(6):860-5. PubMed ID: 16690485 [Abstract] [Full Text] [Related]
18. CD34-positive stromal cells in primary lung carcinomas. Nakayama H, Enzan H, Yamamoto M, Miyazaki E, Hidaka C, Okumichi T, Okumichi A, Kajihara H. Oncol Rep; 2003 Jun 15; 10(5):1313-6. PubMed ID: 12883699 [Abstract] [Full Text] [Related]